What is Clearmind Medicine Inc. Common Shares?
, a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems. The company develops treatments for alcohol use disorders, binge drinking, and eating disorders, as well as weight loss, obesity, and metabolic syndrome, anxiety disorders, post-traumatic stress disorder, depression, and treatment resistant depression. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 1.40M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 327,424 shares $91k | 0 |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 0 |